ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,487.57
1.03%
US Tech 100
19,432.00
1.38%
Dow Jones
38,808.63
0.57%
Brent Oil
83.965
2.24%
Bitcoin
66,693.77
0.08%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NeuBase Therapeutics Inc (NBSE)

  7. NeuBase Therapeutics Inc (NBSE) News

NBSE

NeuBase Therapeutics (NBSE)

NeuBase Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NBSE
DateTimeSourceHeadlineSymbolCompany
06/03/20244:08PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NBSENeuBase Therapeutics Inc
05/31/20244:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
05/22/20244:59PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
05/16/202410:07AMEdgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NBSENeuBase Therapeutics Inc
05/13/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
05/06/20247:30AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NBSENeuBase Therapeutics Inc
04/05/20244:05PMGlobeNewswire Inc.NeuBase Therapeutics Announces Receipt of Notice from NasdaqNASDAQ:NBSENeuBase Therapeutics Inc
03/07/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
02/23/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
01/26/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
01/17/20246:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
12/28/20237:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
12/28/20236:15AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NBSENeuBase Therapeutics Inc
12/22/20236:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
11/27/20239:00AMGlobeNewswire Inc.Psychemedics Corporation Appoints Daniella Mehalik as VP - FinanceNASDAQ:NBSENeuBase Therapeutics Inc
11/09/20234:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NBSENeuBase Therapeutics Inc
11/06/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
11/06/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
10/20/20237:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
10/18/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
09/29/20234:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
09/20/20238:42PMEdgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
09/20/20235:28PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NBSENeuBase Therapeutics Inc
09/18/20234:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
09/18/20234:20PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NBSENeuBase Therapeutics Inc
09/18/20234:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
09/14/20236:03AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NBSENeuBase Therapeutics Inc
09/12/20235:20PMEdgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:NBSENeuBase Therapeutics Inc
09/11/20235:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
09/08/20237:00AMGlobeNewswire Inc.NeuBase Therapeutics Issues Statement Regarding Filing By ShareholderNASDAQ:NBSENeuBase Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NBSE

Your Recent History

USOTC
VXIT
Virexit Technologies (PK)
USOTC
ILST
International Star (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
CNNA
Cann American (CE)
USOTC
FSRN
Fisker (PK)
USOTC
AFFU
Affluence (PK)
USOTC
SMCE
SMC Entertainment (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
GRST
Ethema Health (PK)
USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
TKMO
Tekumo (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
HHSE
Hannover House (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved